Yes, L'Oréal did acquire CeraVe. The world's largest beauty company bolstered its U.S. business in the dynamic active cosmetics segment by signing a definitive agreement to purchase CeraVe along with other skin-care brands.
Details of the Acquisition
L'Oréal's strategic move to acquire CeraVe was part of a larger deal that included two other well-known skin-care brands. This acquisition aimed to strengthen L'Oréal's presence and offerings within the rapidly growing active cosmetics market in the United States.
Here are the key details of the transaction:
- Acquirer: L'Oréal
- Seller: Valeant Pharmaceuticals International Inc.
- Brands Acquired: CeraVe, AcneFree, and Ambi
- Acquisition Price: $1.3 billion in cash
This significant investment underscored L'Oréal's commitment to expanding its portfolio with dermatologist-recommended and science-backed skin care products. CeraVe, known for its ceramide-infused formulations, fit well into L'Oréal's strategy to cater to consumers seeking effective and accessible skin health solutions.
The acquisition was a notable event in the beauty industry, highlighting the value of established, science-driven brands in the competitive skin care market. For more information on beauty industry news, you can refer to publications like WWD.
